Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer.
Miwako OmoriRintaro NoroMasahiro SeikeKuniko MatsudaMariko HiraoAya FukuizumiNatsuki TakanoAkihiko MiyanagaAkihiko GemmaPublished in: Thoracic cancer (2022)
ABC transporter inhibitors may be a promising therapeutic strategy for the purpose of overcoming resistance to topoisomerase inhibitors in patients with SCLC.
Keyphrases